1. Home
  2. Analysis
  3. Entecavir
  4. Hepatitis-c

Entecavir and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Entecavir (entecavir), especially for people who are female, 60+ old, also take Otezla, and have Central nervous system lymphoma.

The phase IV clinical study analyzes which people have Hepatitis c when taking Entecavir. It is created by eHealthMe based on reports of 7,338 people who have side effects when taking Entecavir from the FDA, and is updated regularly.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

What is Hepatitis c?

Hepatitis c is found to be associated with 788 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Jul, 11, 2026

7,338 people reported to have side effects when taking Entecavir.
Among them, 22 people (0.3%) have Hepatitis c.

Could Entecavir cause Hepatitis c?

Among these 22 people:

What is the gender of people who have Hepatitis c when taking Entecavir? *

  • female: 52.63 %
  • male: 47.37 %

What is the age of people who have Hepatitis c when taking Entecavir? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 5.56 %
  • 50-59: 38.89 %
  • 60+: 55.56 %

What are other drugs people take besides Entecavir? *

  1. Magnesium Oxide: 3 people, 13.64%
  2. Alprazolam: 3 people, 13.64%
  3. Eliquis: 3 people, 13.64%
  4. Miralax: 3 people, 13.64%
  5. Digoxin: 3 people, 13.64%
  6. Clobetasol Propionate: 3 people, 13.64%
  7. Metoprolol Tartrate: 3 people, 13.64%
  8. Idhifa: 3 people, 13.64%
  9. Calcipotriene: 3 people, 13.64%
  10. Otezla: 3 people, 13.64%

What are other side effects people have besides Hepatitis c? *

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 7 people, 31.82%
  2. Liver Function Test Abnormal: 5 people, 22.73%
  3. Thrombocytopenia (decrease of platelets in blood): 4 people, 18.18%
  4. Drug Ineffective: 4 people, 18.18%
  5. Constipation: 3 people, 13.64%
  6. Head Injury: 3 people, 13.64%
  7. Gait Disturbance: 3 people, 13.64%
  8. Hepatitis D: 3 people, 13.64%
  9. Dyspnea (difficult or laboured breathing): 3 people, 13.64%
  10. Joint Pain: 3 people, 13.64%

What are the existing conditions these people have? *

  1. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 7 people, 31.82%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 13.64%
  3. Hiv Infection: 2 people, 9.09%
  4. Multiple Myeloma (cancer of the plasma cells): 1 person, 4.55%
  5. High Blood Cholesterol: 1 person, 4.55%
  6. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Entecavir:

Hepatitis c treatments and more:

How severe was Hepatitis c and when was it recovered:

Expand to all the drugs that have ingredients of entecavir:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Entecavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Browse all the conditions that are associated with Hepatitis c:

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Entecavir) and Entecavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.